Some serious buys coming in at the close. Same thing on 6/26 when a block of 500K shares were purchased. I think somebody knows something we don't know, bullish trend!!
Sentiment: Strong Buy
Did you get enough buyers to soak up the shares you were looking to sell?
jeerks. if you left it alone until the close it would have been below the bolllinger and W of -95 -100% and been momo'd for 15% tomorrow.
It was pechstein.carl .
#$%$ to touch that one with a 50 foot pole. That was an obvious short from the start of the phase 3s.
How to identify it:
One, they had zero partners with 3 phase 3s and no income and even talked about how much partnering means to them.
Two, I’m confused by the lack of clinical trial information from the dotgov site for phase 1 or 2 leading to the phase 3s. Without the information of the other trials, it simply looks like someone has hoaxed the investors because it looks incompetent.
Third, their only publications are by the same guy and there is no information or publications around the phase 1 and phase 2s if they ever existed.
I liked that they at least point to where the action is taking place and why their drug might work but there are key elements missing. It’s a bit outside of my knowledge base so I’d have to read up on it but there are too many red flags to touch this volatile puppy.
Good luck day trading this. I hope it doesn’t get locked on you.
Why do all of your posts sound like little angry Asian man rants?
"Shortie gonna go, he die now soon, he caught with his pant down, lose all his moneys, bah hah !
remember who it was or find their question. but I did find something I am going to take a flyer on.
AMPE is exhaustion gapping down with the W% pinned at -100%. Buy at or near the close.
I think its a good bet for a short term bounce but don't let it get away from you
Pretty interesting stuff (data) and I was surprised that we heard no mention of METEOR or cabo; but maybe they were sticking to only drugs currently approved for mRCC.
Sentiment: Strong Buy
wilder, an interesting short CME activity (13 minutes): "new horizons in cancer immunotherapy: management of Metastatic RCC", in medscape education. just out today.
The PCF has compiled a list of 18 questions to be addressed in future research allocation.
"What are the mechanisms of bone pain resolution and vanished 99 Tc uptake with “HGF-1-cMET-ness-multiple kinase inhibitor” treatment?"
Alongside this question on the PCF website is a "before & after" bone scan of a patient's complete response after treatment with cabozantinib - a compelling reminder of the bone phenom controversy that has surrounded Cabo these past few years. As the clinical community differentiates between the neuroendocrine and adenocarcinoma variants of advanced CRPC, I am increasingly convinced that Cabo stands to make a relevant contribution in the prostate space, though this remains dependent upon advances in assay technology. Also on the PCF website: Check out the research presentation by Dr Himisha Beltran on assay development in post-ADT PCa.
It's been a great start to the day for sure, these guys found a play that definitely came out of the gate strong today.
Interesting title coming from the man who romances the farm animals. But, I am glad you value my input. Its too bad you don't follow it. You would have saved a lot of money.
Sentiment: Strong Sell